Brain Imaging Science Identifies Individuals With Suicidal Thoughts

| October 30, 2017

article image
Researchers led by Carnegie Mellon University’s Marcel Just and the University of Pittsburgh’s David Brent have developed an innovative and promising approach to identify suicidal individuals by analyzing the alterations in how their brains represent certain concepts, such as death, cruelty and trouble.

Spotlight

Germer International

Germer International is a recruiting firm that specializes in placing professionals and executives in the Pharmaceutical, Biotech and Medical devices industries. We are a company that builds strong companies, one placement at a time. The firm was founded in 2002 by John Germer, who began his recruiting career in 1987. John Germer and his staff are focused on significantly growing the company by building on John’s years of experience as well as through the team’s relentless pursuit of finding the best candidates for their clients.

OTHER ARTICLES

What do you have to lose taking hydroxychloroquine for coronavirus? Potentially your life

Article | April 10, 2020

The president and some of his close advisors — desperate for a COVID-19 cure — are asking “What do you have to lose?” by taking hydroxychloroquine (HCQ), a strong medication never adequately tested for efficacy or safety in COVID-19 patients. The correct answer to the president’s question, which he doesn’t seem to want to hear, is that we have our lives to lose. The president acknowledges “I’m not a doctor” but this raises the question “What do doctors know about the drug recommended by the president? Most doctors are aware that HCQ can be effective for patients with malaria, arthritis or lupus. If they were to follow the president’s suggestion and prescribe it for COVID-19 patients, they would also like to know that it will benefit some of those patients, at least.

Read More

Pricing of drugs – at what cost?

Article | February 27, 2020

We go into a doctor’s office and leave with a diagnosis and a prescription. Next we stop by the pharmacy. In Germany, if your insurance is not private, you mostly don’t even know the price of your drug because it’s paid for directly by your insurance. You only notice the 5-10 Euros copay. But how is a drug priced in Germany? And (how) does data play a role in helping pharma secure an attractive price point? Let’s fast forward directly to the launch of a new drug. At the time of launch, the pharmaceutical company has to present patient level evidence of the drug’s added value compared to existing comparative therapies. In the first year, however, the drug’s price can be defined freely by the company.

Read More

Artificial intelligence in pharma: utilising a valuable resource

Article | March 11, 2020

The pharmaceutical industry is set to greatly benefit from the use of artificial intelligence (AI), due to its wide range of applications. Sydney Tierney discusses how machine learning can enhance marketing, manufacturing and drug trials. Artificial intelligence (AI) can be applied to nearly every aspect of the pharmaceutical and healthcare industry, to enhance data processing. Adopting the technology will reveal the astonishing potential of the healthcare sector, with success rates flying higher than ever before – especially in the research and development of crucial, life-changing drugs.

Read More

Pharmacist eCare Plan - the newest disrupter in health data exchange?

Article | February 25, 2020

Every member of the health care team shares a common goal of optimizing patient outcomes. Yet each specialty and position of the healthcare team has a unique workflow facilitated by various tools, from an operative report to a progress note. In this regard the pharmacist plays a pivotal function in medication management and requires documentation specific to that role. The Pharmacist eCare Plan (PeCP) allows for an interoperable note to be used in the pharmacy to assist in the exchange of patient information, including active medication list, laboratory results, and payer information. To allow for this, a new type of clinical document architecture for the PeCP was created and standardized for use across pharmacies.

Read More

Spotlight

Germer International

Germer International is a recruiting firm that specializes in placing professionals and executives in the Pharmaceutical, Biotech and Medical devices industries. We are a company that builds strong companies, one placement at a time. The firm was founded in 2002 by John Germer, who began his recruiting career in 1987. John Germer and his staff are focused on significantly growing the company by building on John’s years of experience as well as through the team’s relentless pursuit of finding the best candidates for their clients.

Events